Longevity
Vesugen
Also known as: Lys-Glu-Asp · KED peptide · Vascular bioregulator
Longevity & Mitochondrial In stock Box of 10 vials 2 references
Khavinson tripeptide bioregulator studied in vascular endothelial aging.
Available sizes
| SKU | Per vial | Pack | |
|---|---|---|---|
| VE10 | 10 mg | 10 vials / box | |
| VE20 | 20 mg | 10 vials / box |
Order Vesugen
Pricing is quoted directly and is competitive at every tier — message us with the SKUs you want and quantities for a quote.
Replies within 36 hours. Cryptocurrency (preferred) or card / money-app with a processing fee. COA for this batch available on request.
Vesugen is the synthetic tripeptide Lys-Glu-Asp (KED), developed from vascular peptide fractions in the Khavinson bioregulator series.
KED has been reported to regulate vascular endothelial cell proliferation via epigenetic mechanisms 1 and to show vasoprotective activity in atherosclerosis models 2.
At a glance
- Vascular tripeptide bioregulator
- 10 mg and 20 mg vials
Research use only. All products are sold strictly for laboratory research and development purposes. They are not intended for human or veterinary use, diagnosis, treatment, cure or prevention of any disease. Not for human consumption. Summaries above describe published findings in laboratory and clinical research models and do not constitute claims about this product.
- Form
- Lyophilized powder
- Purity
- HPLC-verified — Certificate of Analysis available on request
- Pack size
- Box of 10 vials
- Storage
- Lyophilized: −20 °C, protected from light (2–8 °C short-term). Reconstituted: 2–8 °C.
- Sequence
- Lys-Glu-Asp
- Formula
- C15H26N4O8
- Mol. weight
- 390.4 g/mol
Sequence, formula and CAS data are provided for identification. Batch-specific purity, mass-spec and HPLC data are on the Certificate of Analysis — ask for it with your order.
- Khavinson VKh, Tarnovskaia SI, Lin'kova NS, et al. [Epigenetic aspects of peptidergic regulation of vascular endothelial cell proliferation during aging]. Adv Gerontol. 2014;27(1):108-14.
- Kozlov KL, Bolotov II, Linkova NS, et al. [Molecular aspects of vasoprotective peptide KED activity during atherosclerosis and restenosis]. Adv Gerontol. 2016;29(4):646-650.
Citations retrieved from PubMed (NCBI). Links open the publisher record via DOI and the PubMed abstract.
Related